- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00664690
Effect of Celecoxib on Transitional Pain After Outpatient Surgery
August 25, 2017 updated by: Lawson Health Research Institute
Sixty adults having shoulder and forearm surgery will receive either placebo or celebrex started preoperatively and continued for 3 days.
Rescue medications required as well as pain scores will be assessed using a patient diary to evaluate the effect of celebrex in controlling transitional pain
Study Overview
Study Type
Interventional
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N
- St. Joseph's Health Care
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients scheduled for elective ambulatory surgery of the shoulder
- ASA I - III
- Able to read English
- Male or female
Exclusion Criteria:
- Allergy to local anesthetic, Cox2, sulpha drug, acetaminophen or oxycodone
- Women who are pregnant or lactating and women of childbearing age and not following acceptable contraceptive precautions
- Any major medical or psychiatric problem
- Those with a known history of narcotic dependence, abuse or chronic narcotic intake
- Patients with known history of peptic ulcer or GI bleeding in the past, ulcers, congestive heart failure, angina or previous heart attack, coagulation problems, venous thrombosis, kidney or liver disease or strokes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: 2
placebo
|
placebo given preop and BID postop
|
|
Experimental: 1
celebrex
|
400 mg celebrex given 1 hour preop and celebrex 200 mg BID postop
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
visual analogue score for pain
Time Frame: post-op period
|
post-op period
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
severity of nausea
Time Frame: post-op period
|
post-op period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
April 18, 2008
First Submitted That Met QC Criteria
April 22, 2008
First Posted (Estimate)
April 23, 2008
Study Record Updates
Last Update Posted (Actual)
August 28, 2017
Last Update Submitted That Met QC Criteria
August 25, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Cyclooxygenase 2 Inhibitors
- Celecoxib
Other Study ID Numbers
- R-04-309
- 10457 (Other Identifier: Fred Hutch/University of Washington Cancer Consortium)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
noiVita SrlsUniversity of Eastern PiedmontCompletedCervical Pain | Pain Management | Lumbar Pain | Muscular | Chronic Pain (Back / Neck)Italy
-
Chinese University of Hong KongNot yet recruitingPain, Acute | Chronic Post Operative Pain | Pain, ChronicHong Kong
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
University of SaskatchewanRoyal University Hospital FoundationCompletedPain | Pain, Acute | Pain, Chronic | Pain, IntractableCanada
Clinical Trials on celebrex
-
Northwell HealthUniversity of Alabama at Birmingham; University of Iowa; Weill Medical College... and other collaboratorsCompletedRecurrent Respiratory PapillomatosisUnited States
-
University of DelawareChristiana Care Health ServicesCompleted
-
Guangxi Medical UniversityUnknown
-
Mannkind CorporationTerminatedMycobacterium Infections, Nontuberculous | MAC Lung Disease | Treatment Refractory MAC Lung DiseaseUnited States, Japan, Taiwan, Australia, South Korea
-
Dong-A ST Co., Ltd.CompletedRheumatoid ArthritisKorea, Republic of
-
Sun Yat-sen UniversityCompletedAnkylosing SpondylitisChina
-
Hunan Kelun Pharmaceutical Co., Ltd.Recruiting
-
M.D. Anderson Cancer CenterCompletedBrain Cancer | Glioblastoma Multiforme | Anaplastic Glioma of BrainUnited States
-
New York State Psychiatric InstituteSuspended
-
Stony Brook UniversityBrain & Behavior Research FoundationCompletedMajor Depressive Disorder | NeuroinflammationUnited States